Stocks Health care LUCD

NASDAQ · Health care

Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Inc. brought in $5.4M of revenue over the twelve months to June 30, 2026, up 24.9% from a year earlier. It posted a net loss of $52.3M. In fiscal 2025 capital spending exceeded operating cash flow by $46.7M. At June 30, 2026 it held $33.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

What Lucid Diagnostics Inc. does

Lucid Diagnostics Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LUCD.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where LUCD ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Lucid Diagnostics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 22, 2026
   Investor disclosure 8-K
2. August 13, 2026
   Quarterly results 8-K
3. August 12, 2026
   Quarterly report 10-Q · period to June 30, 2026
4. June 24, 2026
   Bylaws or fiscal year changed 8-K
5. May 14, 2026
   Quarterly results 8-K
6. May 13, 2026
   Quarterly report 10-Q · period to March 31, 2026
7. April 30, 2026
   Additional proxy material DEFA14A
8. April 30, 2026
   Annual report to shareholders ARS
9. April 30, 2026
   Proxy statement DEF 14A
10. April 24, 2026
    Investor disclosure 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 21, 2026. Insider transactions on SEC

Insider trades

What the people running Lucid Diagnostics Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about LUCD

What does Lucid Diagnostics Inc. do?

Lucid Diagnostics Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LUCD.

Is Lucid Diagnostics Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $52.3M on revenue of $5.4M.

How much revenue does Lucid Diagnostics Inc. make?

Over the twelve months to June 30, 2026 Lucid Diagnostics Inc. reported revenue of $5.4M. That is 24.9% more than a year earlier.

When did Lucid Diagnostics Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 22, 2026.

Similar companies

Compare LUCD with

Compare LUCD with any company

Follow LUCD

Get an email when Lucid Diagnostics Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LUCD: get an email when it files

Where the numbers come from

Financial figures are the values Lucid Diagnostics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.